Showing results (71-80 of 264) with videos related to

Sort By:
Pageof 27
European Journal of Dermatology : EJD|June 29, 2018
Greater improvement in quality of life outcomes in patients using fixed-combination calcipotriol plus betamethasone dipropionate aerosol foam versus gel: results from the PSO-ABLE studyChristopher Em Griffiths, Linda Stein Gold, Frédéric Cambazard, et al.
Expert Opinion on Biological Therapy|March 29, 2003
Modulating T cell responses for the treatment of psoriasis: a focus on efalizumabJennifer Clay Cather, J Christian Cather, Alan Menter
Proceedings (Baylor University. Medical Center)|April 7, 2012
Widespread dermal ulcerations and bullaeJay Wofford, Mahir Patel, Allison Readinger, et al.
Dermatology and Therapy|December 31, 2015
A Review of Biologic Therapies Targeting IL-23 and IL-17 for Use in Moderate-to-Severe Plaque PsoriasisMolly Campa, Bobbak Mansouri, Richard Warren, et al.
Dermatology and Therapy|January 18, 2020
The Validity of Cutaneous Body Image as a Construct and as a Mediator of the Relationship Between Cutaneous Disease and Mental HealthSarah B Hinkley, Shayla C Holub, Alan Menter
Chemistry Central Journal|April 27, 2012
Chemical consequences of cutaneous photoageingSarah A Thurstan, Neil K Gibbs, Abigail K Langton, et al.
Journal of the American Academy of Dermatology|February 28, 2004
Combination therapy to treat moderate to severe psoriasisMark Lebwohl, Alan Menter, John Koo, et al.
Proceedings (Baylor University. Medical Center)|April 6, 2019
Successful treatment of atopic dermatitis with the JAK1 inhibitor oclacitinibIsabel M Haugh, Ian T Watson, M Alan Menter
Journal of Drugs in Dermatology : JDD|June 12, 2014
A retrospective analysis of 72 patients on prior efalizumab subsequent to the time of voluntary market withdrawal in 2009Elizabeth Farley Prater, Antoinette Day, Mahir Patel, et al.
Expert Opinion on Biological Therapy|March 12, 2010
The use of ustekinumab in autoimmune diseaseCaitriona Ryan, Breck Thrash, Richard B Warren, et al.
Pageof 27